These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

966 related items for PubMed ID: 23642215

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Race and the prognostic influence of p53 in women with breast cancer.
    Dookeran KA, Dignam JJ, Holloway N, Ferrer K, Sekosan M, McCaskill-Stevens W, Gehlert S.
    Ann Surg Oncol; 2012 Jul; 19(7):2334-44. PubMed ID: 22434242
    [Abstract] [Full Text] [Related]

  • 4. Age-specific incidence of breast cancer subtypes: understanding the black-white crossover.
    Clarke CA, Keegan TH, Yang J, Press DJ, Kurian AW, Patel AH, Lacey JV.
    J Natl Cancer Inst; 2012 Jul 18; 104(14):1094-101. PubMed ID: 22773826
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. HER2 status and disparities in luminal breast cancers.
    Holowatyj AN, Ruterbusch JJ, Ratnam M, Gorski DH, Cote ML.
    Cancer Med; 2016 Aug 18; 5(8):2109-16. PubMed ID: 27250116
    [Abstract] [Full Text] [Related]

  • 14. Race and risk of subsequent aggressive breast cancer following ductal carcinoma in situ.
    Liu Y, West R, Weber JD, Colditz GA.
    Cancer; 2019 Sep 15; 125(18):3225-3233. PubMed ID: 31120565
    [Abstract] [Full Text] [Related]

  • 15. Molecular breast cancer subtypes in premenopausal and postmenopausal African-American women: age-specific prevalence and survival.
    Ihemelandu CU, Leffall LD, Dewitty RL, Naab TJ, Mezghebe HM, Makambi KH, Adams-Campbell L, Frederick WA.
    J Surg Res; 2007 Nov 15; 143(1):109-18. PubMed ID: 17950079
    [Abstract] [Full Text] [Related]

  • 16. Breast Cancer Survival Analysis Based on Immunohistochemistry Subtypes (ER/PR/HER2): a Retrospective Cohort Study.
    Poorolajal J, Nafissi N, Akbari ME, Mahjub H, Esmailnasab N, Babaee E.
    Arch Iran Med; 2016 Oct 15; 19(10):680-686. PubMed ID: 27743431
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Disparities in the risk of the ER/PR/HER2 breast cancer subtypes among Asian Americans in California.
    Parise C, Caggiano V.
    Cancer Epidemiol; 2014 Oct 15; 38(5):556-62. PubMed ID: 25172158
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 49.